Turmeric Recall Issued Due to High Lead Levels
High levels of lead have led to a recall for turmeric after random sample testing detected that PRAN brand Spice Powder could pose a risk of future mental and physical developmental deficiencies.
The PRAN turmeric recall was announced by the FDA on October 8, after the New York State Health Department found that the product contains 28 parts per million of lead, well over the allowable rate. To date, one illness has been reported.
The recall includes PRAN brand Spice Powder Turmeric with UPC code 8 31730 00551 packaged in clear plastic jars that weigh 8.82 ounces. The products also have a “BEST BEFORE” date of “02 SEP 14” written on the packaging.
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
The affected products were manufactured by Asia Cash & Carry Inc., of Maspeth, New York were they were distributed for sale to retail stores in New York, Pennsylvania, Massachusetts, Virginia, and Illinois.
Accumulation of lead in the body can cause severe harm over time, especially in pregnant women, infants, and young children because lead can cause delayed mental and physical development as well as learning deficiencies.
The U.S. Centers for Disease Control and Prevention (CDC) has even warned the public of a study done over the past decade by the National Health and Nutrition Examination survey that estimated roughly 535,000 children ages 1-5, or about 2.6% of such children in the U.S., have levels of lead in their blood that place them at risk for adverse health effects.
The FDA advises Consumers with possibly affected PRAN spice powder not to consume the product and return it to its place of purchase or contact Asia Cash & Carry Inc. at 1-718-894-2505 for a full refund.
"*" indicates required fields
More Top Stories
With thousands of Bard hernia mesh lawsuits pending in the federal court system, a fourth bellwether trial will be held in the spring, involving allegations that defects with Bard 3DMax caused painful and permanent injuries.
A Tepezza hearing loss lawsuit accuses the manufacturer of failing to warn doctors to conduct hearing tests, which could have helped a woman avoid permanent hearing damage.
A South Dakota man has filed one of the first gastroparesis lawsuits against Ozempic manufacturers, alleging that users have not been adequately warned about the risk of severe vomiting and long-term stomach side effects.